Nektar Therapeutics sell kostojunior
Start price
30.06.25
/
0%
€0.58
Target price
30.06.26
-
Performance (%)
-
End price
30.06.26
-
Summary
This prediction was cancelled by the user.Nektar is a clinical-stage biopharmaceutical company focused on developing treatments for cancer, autoimmune diseases, and chronic pain. The company's pipeline includes product candidates based on its proprietary drug delivery technology, which improves the delivery and effectiveness of drugs in the body. Some of its most advanced candidates include NKTR-214, a cancer immunotherapy, and NKTR-181, a non-opioid pain medication. Nektar is listed on the NASDAQ exchange under the ticker symbol NKTR.
AI-generated
Performance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Nektar Therapeutics | - | - | - |
| iShares Core DAX® | 1,72 % | 3,37 % | 5,89 % |
| iShares Nasdaq 100 | -4,56 % | -4,24 % | 21,39 % |
| iShares Nikkei 225® | -7,12 % | -11,87 % | 42,36 % |
| iShares S&P 500 | -0,89 % | 1,69 % | 19,49 % |
Comments by kostojunior for this prediction
In the thread Nektar Therapeutics diskutieren
Sell Nektar Therapeutics
In the thread Trading Nektar Therapeutics
Die von kostojunior gewählte maximale Laufzeit wurde überschritten